CERS

MKT CAP:$615M

Cerus Corporation

Market Cap

$615M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$3.18+$1.21 (+61.42%)

Jul 15, 2026

52W High $3.2852W Low $1.16

Company Details

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for c...

Leadership

William M. Greenman

Executive Chairman of the Board

Vivek K. Jayaraman

CEO, President & Director

Kevin D. Green CPA

VP of Finance & CFO

Chrystal N. Jensen J.D.

Chief Legal Officer, General Counsel & Secretary

Richard J. Benjamin MBChB, Ph.D.

Chief Medical Officer

Timothy J. Lee

Head of Investor Relation

Lainie Corten

Vice President of Global Marketing

IPO Date

Jan 30, 1997

Website

www.cerus.com

Key Metrics TTM

Revenue

$205M

+517.1% YoY

Net Income

-$6M

EPS (Diluted)

Free Cash Flow

-$1M

Revenue / Share

$1.06

Gross Margin

55.7%

Operating Margin

0.4%

Net Margin

-2.9%

FCF Margin

-0.6%

P/S

3.0x

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee